Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.32
+0.37 (1.24%)
Sep 16, 2026, 9:46 AM EDT - Market open
Viking Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $85 | Buy | Maintains | $85 | +180.34% | Sep 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $100 | Buy | Maintains | $100 | +229.82% | Aug 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $75 → $65 | Buy | Maintains | $75 → $65 | +114.38% | Aug 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 | Buy | Maintains | $100 | +229.82% | Aug 3, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $70 | Buy | Reiterates | $70 | +130.87% | Jul 31, 2026 |
| Jefferies | Jefferies | Buy Maintains $101 | Buy | Maintains | $101 | +233.11% | Jul 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $95 | Buy | Maintains | $95 | +213.32% | Jul 30, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $83 | Buy | Maintains | $83 | +173.75% | Jul 30, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.